ResMed (RMD) Reports In-Line Q3 EPS
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $191.26 +1.49%
Revenue Growth %: +13.1%
Financial Fact:
Other, net (note 12): 1.27M
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: +13.1%
Financial Fact:
Other, net (note 12): 1.27M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q3 EPS of $0.65, in-line with the analyst estimate of $0.65. Revenue for the quarter came in at $422.5 million versus the consensus estimate of $425.76 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
- This digital health stock is ready to re-rate higher: Goldman
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
